Trial Design Solutions
-
Why Australia Is The Best Place In The World For Early Phase Studies
8/8/2024
The Australian Advantage is about saving time and minimizing costs while generating internationally accepted data in preparation for the next Phase.
-
The #1 Rated Leader In DCT Now Offers The Vaccine Pathway
6/17/2022
Explore an expertly crafted package of programs, products, and expertise addressing the unique challenges of vaccine research.
-
The Asia Drug Development Advantage
8/8/2024
Avance Clinical has located its Asia hub operations in Seoul, South Korea which is highly regarded for its advanced technology and scientific and medical excellence.
-
Central Nervous System Drug Development
1/16/2026
CNS drug development faces unique hurdles — from high placebo response to complex protocols and recruitment challenges. Discover strategies to streamline trials, optimize planning, and accelerate delivery of innovative therapies for patients with critical unmet needs.
-
Biostatistics: End-To-End Management
7/31/2024
Discover how a team of biostatistics and pharmacokinetics experts can offer specialized guidance for clinical trial design and analysis.
-
Ophthalmic Clinical Research Services
1/26/2023
With over 40 clinical trials conducted in the area of ophthalmology, Altasciences combines depth of knowledge and expert capabilities to offer you a full range of early ophthalmic clinical development.
-
Home Trial Support: The Engine Powering DCT
8/10/2021
By conducting trial visits outside of the site, physicians can expand their reach, making drug development more accessible. Read about how MRN's Home Trial Support "HTS" is the engine powering DCTs.
-
Engage The Right Participants Faster
9/8/2025
Clinical trial recruitment doesn’t have to be slow, costly, or unpredictable. Find the right recruit strategy and digital recruit model for your study.
-
Rave RTSM: Direct-To-Patient
10/3/2022
As the healthcare industry continues to deepen its focus on virtual trials and patient-centricity, the popularity of Direct-to-Patient (DtP) services in the clinical trial setting has grown significantly. Rave RTSM DtP (Randomization and Trial Supply Management Direct to Patient) brings investigational medicinal products (IMP) directly to a patient’s home, bypassing the need for the patient to travel directly to a site.
-
PULSE: Empowering Every Phase of Your Clinical Journey
1/22/2026
A flexible RTSM platform improves study startup, real‑time design updates, oversight, and global supply management, enabling faster execution, clearer visibility, and streamlined trial operations.